Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease [2]

Annals of Internal Medicine

Volumn 161, Issue 1, 2014, Pages 81-82

  Levin, Adeera ^a   Stevens, Paul E ^b   Coresh, Josef ^c   Levey, Andrew ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCITRIOL; CREATININE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE;

CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; MASS SCREENING; NOTE;

HUMANS; MASS SCREENING; RENAL INSUFFICIENCY, CHRONIC;

EID: 84903594154     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L14-5013-2     Document Type: Letter

References (5)

1. Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159:835-47. [PMID: 24145991]
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
3. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337-414.
4. Tomlinson LA, Abel GA, Chaudhry AN, Tomson CR, Wilkinson IB, Roland MO, et al. ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS One. 2013;8:e78465. [PMID: 24223154]
5. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl. 2013;3:259-305.